These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


331 related items for PubMed ID: 27177173

  • 1. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report.
    Goto Y, Furuno Y, Kawabe T, Ohwada K, Tatsuzawa K, Sasajima H, Hashimoto N.
    J Neurosurg; 2017 Feb; 126(2):431-434. PubMed ID: 27177173
    [Abstract] [Full Text] [Related]

  • 2. Role of Denosumab in Endoscopic Endonasal Treatment for Juvenile Clival Giant Cell Tumor: A Case Report and Review of the Literature.
    Inoue A, Ohnishi T, Kohno S, Nishikawa M, Nishida N, Ohue S.
    World Neurosurg; 2016 Jul; 91():674.e1-6. PubMed ID: 27113403
    [Abstract] [Full Text] [Related]

  • 3. Denosumab Treatment for a Residual Giant Cell Tumor of the Clivus: A Case Report and Review of the Literature.
    Huh A, Villelli N, Martinez D, Ting J, Birhiray R, Payner TD, Kulwin CG.
    World Neurosurg; 2018 Oct; 118():98-101. PubMed ID: 30010069
    [Abstract] [Full Text] [Related]

  • 4. Preoperative Cytoreduction of Clival Giant Cell Tumor: An Effective Replication of the Systemic Modality in the Skull Base.
    Sekar A, Rudrappa S, Gopal S, Ghosal N, Gupta V, Ts L.
    World Neurosurg; 2018 Nov; 119():97-102. PubMed ID: 30075260
    [Abstract] [Full Text] [Related]

  • 5. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
    Al Farii H, McChesney G, Patel SS, Rhines LD, Lewis VO, Bird JE.
    Spine J; 2024 Jun; 24(6):1056-1064. PubMed ID: 38301904
    [Abstract] [Full Text] [Related]

  • 6. Endoscopic transsphenoidal anterior petrosal approach for locally aggressive tumors involving the internal auditory canal, jugular fossa, and cavernous sinus.
    Shin M, Kondo K, Hanakita S, Hasegawa H, Yoshino M, Teranishi Y, Kin T, Saito N.
    J Neurosurg; 2017 Jan; 126(1):212-221. PubMed ID: 27035173
    [Abstract] [Full Text] [Related]

  • 7. Denosumab treatment for progressive skull base giant cell tumor of bone in a 14 year old female - a case report and literature review.
    Bardakhchyan S, Kager L, Danielyan S, Avagyan A, Karamyan N, Vardevanyan H, Mkhitaryan S, Papyan R, Zohrabyan D, Safaryan L, Sargsyan L, Harutyunyan L, Hakobyan L, Iskanyan S, Tamamyan G.
    Ital J Pediatr; 2017 Mar 29; 43(1):32. PubMed ID: 28356124
    [Abstract] [Full Text] [Related]

  • 8. Endoscopic endonasal treatment of a large clival giant cell tumor invading the cavernous sinus and temporal lobe.
    Yildirim AE, Divanlioglu D, Cetinalp NE, Ozhamam E, Belen AD.
    J Craniofac Surg; 2014 Mar 29; 25(2):446-8. PubMed ID: 24481168
    [Abstract] [Full Text] [Related]

  • 9. A single-center experience with giant cell tumors of sphenoid bone and clivus.
    Yaprak Bayrak B, Özcan E, Vural Ç, Emengen A, Çabuk B, Ceylan S.
    Tumori; 2021 Dec 29; 107(6):NP94-NP100. PubMed ID: 34374310
    [Abstract] [Full Text] [Related]

  • 10. Sustained long-term complete regression of a giant cell tumor of the spine after treatment with denosumab.
    Mattei TA, Ramos E, Rehman AA, Shaw A, Patel SR, Mendel E.
    Spine J; 2014 Jul 01; 14(7):e15-21. PubMed ID: 24534393
    [Abstract] [Full Text] [Related]

  • 11. Successful total en bloc spondylectomy of the L3 vertebra with a paravertebral giant cell tumor following preoperative treatment with denosumab: a case report.
    Kinoshita H, Orita S, Yonemoto T, Ishii T, Iwata S, Kamoda H, Tsukanishi T, Inage K, Abe K, Inoue M, Norimoto M, Umimura T, Fujimoto K, Shiga Y, Kanamoto H, Furuya T, Takahashi K, Ohtori S.
    J Med Case Rep; 2019 Apr 26; 13(1):116. PubMed ID: 31023361
    [Abstract] [Full Text] [Related]

  • 12. Invasive Giant Cell Tumor of the Lateral Skull Base: A Systematic Review, Meta-Analysis, and Case Illustration.
    Freeman JL, Oushy S, Schowinsky J, Sillau S, Youssef AS.
    World Neurosurg; 2016 Dec 26; 96():47-57. PubMed ID: 27269210
    [Abstract] [Full Text] [Related]

  • 13. Giant cell tumors of the spine: has denosumab changed the treatment paradigm?
    Goldschlager T, Dea N, Boyd M, Reynolds J, Patel S, Rhines LD, Mendel E, Pacheco M, Ramos E, Mattei TA, Fisher CG.
    J Neurosurg Spine; 2015 May 26; 22(5):526-33. PubMed ID: 25700239
    [Abstract] [Full Text] [Related]

  • 14. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
    Wojcik J, Rosenberg AE, Bredella MA, Choy E, Hornicek FJ, Nielsen GP, Deshpande V.
    Am J Surg Pathol; 2016 Jan 26; 40(1):72-80. PubMed ID: 26414220
    [Abstract] [Full Text] [Related]

  • 15. Clinical and pathological results of denosumab treatment for giant cell tumors of bone: Prospective study of 14 cases.
    Deveci MA, Paydaş S, Gönlüşen G, Özkan C, Biçer ÖS, Tekin M.
    Acta Orthop Traumatol Turc; 2017 Jan 26; 51(1):1-6. PubMed ID: 27784623
    [Abstract] [Full Text] [Related]

  • 16. Combining of serial embolization and denosumab for large sacropelvic giant cell tumor: Case report of 3 cases.
    Ji T, Yang Y, Wang Y, Sun K, Guo W.
    Medicine (Baltimore); 2017 Aug 26; 96(33):e7799. PubMed ID: 28816971
    [Abstract] [Full Text] [Related]

  • 17. Pathogenesis of Osteosclerotic Change Following Treatment with an Antibody Against RANKL for Giant Cell Tumour of the Bone.
    Rosario M, Takeuchi A, Yamamoto N, Hayashi K, Miwa S, Higuchi T, Abe K, Taniguchi Y, Aiba H, Tanzawa Y, Murakami H, Tsuchiya H.
    Anticancer Res; 2017 Feb 26; 37(2):749-754. PubMed ID: 28179326
    [Abstract] [Full Text] [Related]

  • 18. Giant cell tumor of the thoracic spine completely removed by total spondylectomy after neoadjuvant denosumab therapy.
    Yonezawa N, Murakami H, Kato S, Takeuchi A, Tsuchiya H.
    Eur Spine J; 2017 May 26; 26(Suppl 1):236-242. PubMed ID: 28396950
    [Abstract] [Full Text] [Related]

  • 19. Giant cell tumor of the ischium: Imaging findings before and after neoadjuvant denosumab.
    Tordjman M, Larousserie F, Mompoint D, Biau D, Lebreton C, Carlier RY.
    Diagn Interv Imaging; 2017 May 26; 98(5):447-450. PubMed ID: 28377083
    [No Abstract] [Full Text] [Related]

  • 20. Giant cell tumor: rapid recurrence after cessation of long-term denosumab therapy.
    Matcuk GR, Patel DB, Schein AJ, White EA, Menendez LR.
    Skeletal Radiol; 2015 Jul 26; 44(7):1027-31. PubMed ID: 25712768
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.